+1.650.627.4531 inquiry@medeortx.com
Contact Us| Find us on:

Medeor Therapeutics Expands Executive Team

SAN MATEO, Calif.April 4, 2018 — Medeor Therapeutics, Inc., a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of personalized cellular immunotherapies, today announced the appointment of Iqbal Husain, Ph.D., as its Senior Vice President, Program Management, and Michael Zdanowski as its Vice President, Biopharmaceutical Operations.

“We are delighted to welcome Iqbal and Mike to Medeor and our executive leadership team,” said Steven R. Deitcher, M.D., President and Chief Executive Officer of Medeor.  “As we move into multiple late-stage clinical trials during 2018, we anticipate that Iqbal’s and Mike’s combined expertise and experience will catalyze operational success.  Our newly-expanded executive team has the acumen and skills to drive our clinical programs forward.”

Open Press Release >>